HOME › DRUGS › ROPEGINTERFERON ALFA-2B-NJFT
ACTIVE SUBSTANCE / INN

ROPEGINTERFERON ALFA-2B-NJFT

Brand name(s): BESREMI
FDA LISTED
PRESCRIPTION
BLA761166
ACTIVE SUBSTANCE
Ropeginterferon Alfa-2B-Njft
REGULATORS
FDA
SPONSORS / MAH
PHARMAESSENTIA CORP
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BESREMIBLA761166PHARMAESSENTIA CORPPrescription

FULL INTELLIGENCE ON ROPEGINTERFERON ALFA-2B-NJFT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →